Vue.component('pst-ins-overview', { template: '
' + '' + '

Persistence to Basal Insulin (PST-INS)

' + '
' + '' + '

Description

' + '
' + '' + '

The percentage of individuals ≥18 years of age who were treatment persistent to basal insulin during the measurement year.

' + '

A higher rate indicates better performance.

' + '
' + '' + '

Additional Information

' + '
' + '' + '' + '

Intended Use

' + '
' + '' + '

Performance measurement for health plans.

' + '
' + '
' + '' + '' + '

Data Sources

' + '
' + '' + '

Medical and prescription claims data.

' + '
' + '
' + '' + '' + '

Denominator

' + '
' + '' + '

Individuals with ≥1 prescription claims for basal insulin during the measurement year.

' + '
' + '
' + '' + '' + '

Exclusions

' + '
' + '' + '
    ' + '
  • Gestational Diabetes
  • ' + "
  • Hospice
  • " + "
  • End-Stage Renal Disease (ESRD)
  • " + "
  • ≥1 prescription claim for mixed insulin
  • " + "
  • ≥1 prescription claim for regular insulin (U-500)
  • " + '
' + '
' + '
' + '' + '' + '

Numerator

' + '
' + '' + '

The number of individuals with continued use of basal insulin throughout the treatment period (individuals with all refills for basal insulin occurring on or prior to the expected refill date).

' + '
' + '
' + '
' }); Vue.component('pst-ins-ref-1', { template: '' + '' + '1' + '' }); Vue.component('pst-ins-rationale', { template: '
' + '' + '

Rationale

' + '
' + '' + "

" + '
' + '
' }); Vue.component('pst-ins', { template: '
' + '' + /*'' + '' +*/ '



' + '
', props: { rationale: { default: false }, faqs: { default: false } } });